Brief: Atara Biotherapeutics Q3 EPS USD -2.93
12/11/2024 21:01
Nov 12 (Reuters) - Atara Biotherapeutics Q3 revenue USD 40.19 million vs. IBES estimate USD 35.2 million. * Q3 operating income USD -21.757 million * Q3 net income USD -21.909 million
Recent news on Atara Biotherapeutics
See all newsBrief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
Brief: Atara Biotherapeutics Q1 EPS USD -0.29
NASDAQ RESUMED AT 03:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:30 PM